Executive Series - Opthea Ltd (OPT) CEO & Managing Director, Dr Megan Baldwin
Tom Piotrowski speaks with Opthea Ltd (OPT) CEO & Managing Director, Dr Megan Baldwin about its recent name change from Circadian Technologies, the surge in its share price over the past six months, and the upcoming results of its Phase 1 trial To view more Executive Series interviews, visit: (VIEW LINK)
3 topics
most popular
Asset Allocation
Macquarie reveals its 16-stock "recession-proof" portfolio
Hans Lee,
Livewire Markets
Equities
Morgans’ 12 large-cap best ideas - June 2022
Andrew Tang,
Morgans Financial